Poulton Jeffrey V. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
9
Insider Sells Sum
$2.61M

Insider Activity of Poulton Jeffrey V.

According to the SEC Form 4 filings, Poulton Jeffrey V., being in a position of

  1. EVP, Chief Financial Officer at Alnylam Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 12384 shares for $4.2M,
    over all time since 2023-04-27, has bought 0 shares, and sold 31084 shares for $9.69M.

Biography of Poulton Jeffrey V.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $4,198,3155100

Comparison of Insiders on Amount of Buys and Sells

2026-03-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
2,468
0.0018%
$323.08$797,351-12.54%
2026-03-02SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
2,206
0.0016%
$327.65$722,801-11.89%
2026-02-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
2,242
0.0017%
$310.08$695,201-8.34%
2026-01-12SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
2,780
0.0021%
$362.87$1.01M-20.79%
2026-01-12SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
2,688
0.002%
$362.42$974,197-20.79%
2025-10-02SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
3,821
0.0029%
$452.05$1.73M-31.16%
2025-08-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
2,274
0.0017%
$453.27$1.03M-27.2%
2025-08-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
273
0.0002%
$449.70$122,769-27.2%
2025-03-03SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
1,264
0.001%
$243.78$308,141+44.46%
2025-02-28SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
796
0.0006%
$241.70$192,390+42.61%
2025-02-14SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
967
0.0007%
$255.17$246,750+37.21%
2024-11-26SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
1,682
0.0013%
$250.98$422,144+18.3%
2024-06-25SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
1,605
0.0012%
$231.00$370,747+9.36%
2024-02-28SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
574
0.0005%
$155.30$89,145+58.99%
2024-02-16SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
1,007
0.0008%
$148.06$149,099+66.97%
2023-08-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
3,460
0.0028%
$185.85$643,037-8.87%
2023-04-27SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Financial Officer
977
0.0008%
$194.59$190,113-8.12%
Total: 17
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.